Camurati-Engelmann Disease - 23 Studies Found Completed : Angiotensin II Antagonism of TGF-Beta 1 : Diabetic Nephropathy Hypertension : 2006-04-28 : Drug: Candesartan Active, not recruiting : TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC : EBV-positive Nasopharyngeal Carcinoma : 2014-02-14 : Biological: DNR.NPC-specific T cells Active, not recruiting : Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy : HER2 Positive Malignancies : 2009-04-24 : Biological: TGFBeta resistant HER2/EBV-CTLs Each patient w Completed : Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers : Healthy : 2008-04-07 : Drug: P144 cream P144 cream wi Completed : Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects : Hypertension : 2014-11-28 Completed : Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 : Pancreatic Neoplasms Melanoma Colorectal Neoplasms : 2009-02-12 : Drug: AP 12009 Initial scheme: AP 12009 (trabedersen), dos Recruiting : Study of Lymphodepletion Plus Adoptive Cell Transfer With TGF-beta Resistant (DNRII) and NGFR Transduced T-Cells Followed by High Dose Interleukin-2 in Participants With Metastatic Melanoma : Melanoma : 2013-09-27 : Drug: Cyclophosphamide 60 mg/k Completed : Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis : Systemic Sclerosis Scleroderma : 2002-08-12 : Drug: Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody Completed : Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D : SLE : 2017-05-13 : Dietary Supplement: "Cholecalciferol" and "C. Xanthorrhiza&qu Recruiting : Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer : Prostate Cancer : 2015-05-20 : Drug: Enzalutamide 160mg of en Next >>>
